Background illustration for clinical trials search

Paid Clinical Trials Princeton

Discover 1,664 paid clinical trials in Princeton, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,664

A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

for

Chronic Graft-versus-host-disease

Location: New Brunswick NJ, Philadelphia PA, Hackensack NJ,

Sponsor: Incyte Corporation

Sex: All

Age: 12+

Code: NCT06585774

Phase3, Recruiting

A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer

for

Breast Cancer, TNBC - Triple-Negative Breast Cancer,

Location: New Brunswick NJ, Westbury NY, Baltimore MD, Canton OH,

Sponsor: Processa Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06568692

Phase2, Recruiting

Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma

for

Carcinoma, Hepatocellular, Liver Cell Carcinoma

Location: New Brunswick NJ, The Bronx NY

Sponsor: Rutgers, The State University of New Jersey

Sex: All

Age: 18+

Code: NCT05366829

Phase2, Recruiting

Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients

for

Melanoma Stage IIIB, Melanoma Stage IIIC, Melanoma Stage IIID

Location: New Brunswick NJ, Philadelphia PA, Ney York NY,

Sponsor: Philogen S.p.A.

Sex: All

Age: 18+

Code: NCT03567889

Phase3, Recruiting

A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors

for

Advanced Solid Tumor

Location: New Brunswick NJ, New York NY, Cleveland OH,

Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT05932862

Phase1, Recruiting

A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer

for

Metastatic HER2-positive Breast Cancer

Location: New Brunswick NJ, Philadelphia PA, New York NY,

Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06435429

Phase3, Recruiting

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

for

Superficial Bladder Cancer,

Location: New Brunswick NJ, Philadelphia PA, Voorhees Township NJ,

Sponsor: enGene, Inc.

Sex: All

Age: 18+

Code: NCT04752722

Phase1, Phase2, Recruiting

A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

for

Non-Muscle Invasive Bladder Cancer

Location: New Brunswick NJ, Bala-Cynwyd PA, Los Alamitos CA,

Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06319820

Phase3, Recruiting

A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas

for

B-cell Non-Hodgkins Lymphoma (B-NHL)

Location: New Brunswick NJ, New York NY, Boston MA, Louisville KY,

Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05685173

Phase1, Recruiting

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

for

Carcinoma, Non-Small-Cell Lung

Location: New Brunswick NJ, Philadelphia PA, Summit NJ,

Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06667076

Phase2, Recruiting

Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)

for

Breast Neoplasms, Breast Cancer

Location: New Brunswick NJ, Fairfax VA, Boston MA, Kingston,

Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06686394

Phase1, Phase2, Recruiting

Luminal Bladder Cancer Effective Response to Neoadjuvant Chemotherapy (LUMBER-NAC)

for

Bladder Cancer

Location: New Brunswick NJ

Sponsor: Rutgers, The State University of New Jersey

Sex: All

Age: 18 - 70+

Code: NCT07762586

Phase2, Recruiting

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma

for

Diffuse Large B-cell Lymphoma (DLBCL)

Location: New Brunswick NJ, Stony Brook NY, Baltimore MD,

Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06091865

Phase3, Recruiting

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

for

Lymphoma

Location: New Brunswick NJ, Philadelphia PA, New York NY,

Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT07015242

Phase2, Recruiting

Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment

for

Recurrent Glioblastoma, IDH-Wildtype,

Location: New Brunswick NJ, New York NY, Pittsburgh PA,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05432804

Phase1, Phase2, Recruiting

FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

for

Ras-mutated Metastatic Colorectal Cancer, mCRC,

Location: New Brunswick NJ, Florham Park NJ, Canton OH,

Sponsor: Oncolytics Biotech

Sex: All

Age: 18+

Code: NCT07446322

Phase2, Recruiting

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

for

Gastric Adenocarcinoma,

Location: New Brunswick NJ, Basking Ridge NJ, Middletown NJ,

Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 18+

Code: NCT07001748

Phase2, Phase3, Recruiting

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

for

Acute Myeloid Leukemia

Location: New Brunswick NJ, Basking Ridge NJ, Middletown NJ,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06672146

Phase2, Recruiting

Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer

for

Extensive Stage Lung Small Cell Cancer

Location: New Brunswick NJ, Philadelphia PA, Morristown NJ,

Sponsor: PrECOG, LLC.

Sex: All

Age: 18+

Code: NCT07057791

Phase2, Recruiting

Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

for

Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,

Location: New Brunswick NJ, Willow Grove PA, Livingston NJ,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07195734

Phase2, Recruiting

Paid Clinical Trials Princeton

Filter results

A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer

Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma

Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients

A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors

Interested in new trials?

A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)

Luminal Bladder Cancer Effective Response to Neoadjuvant Chemotherapy (LUMBER-NAC)

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment

FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer

Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer